Hatch BioFund Invests in Optimeos Life Sciences to Advance Nanoparticle Drug Delivery Platform

Delivering complex therapeutic molecules safely and efficiently remains one of the biggest challenges in the development of next-generation medicines. While... Read More

The post Hatch BioFund Invests in Optimeos Life Sciences to Advance Nanoparticle Drug Delivery Platform appeared first on citybiz.